2014
DOI: 10.1111/cbdd.12375
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Evaluation of a New Series of 3,5‐bis((5‐bromo‐6‐methyl‐2‐t‐aminopyrimidin‐4‐yl)thio)‐4H‐1,2,4‐triazol‐4‐amines and their Cyclized Products ‘Pyrimidinylthio Pyrimidotriazolothiadiazines’ as 15‐ Lipo‐Oxygenase Inhibitors

Abstract: A series of new 3,5-bis((5-bromo-6-methyl-2-t-aminopyrimidin-4-yl)thio)-4H-1,2,4-triazol-4-amines and their cyclized products 'pyrimidinylthio pyrimidotriazolothiadiazines' were designed, synthesized, and evaluated as potential inhibitors of 15-lipo-oxygenase (15-LO). Their syntheses started by initial condensation of 2:1 equivalents of pyrimidine with triazole and subsequent nucleophilic displacement of the chlorine atoms with secondary amines and finally cyclocondensation in the presence of NaNH2. The compou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
20
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 21 publications
(20 citation statements)
references
References 40 publications
0
20
0
Order By: Relevance
“…Furthermore, five-membered heterocycles like pyrazole-based sulfonamide and sulfamides (IC 50 = 1.4 nM, r12/15-LOX),23 oxadiazole or oxazole derivatives as ML094 (IC 50 = 10 nM, h-15-LOX-1)24 and ML351 (IC 50 = 200 nM, h-15-LOX-1)25 but also imidazole-based compounds (IC 50 = 75 nM, r12/15-LOX)26 are reported as 15-LOX inhibitors. In addition, indolizine (IC 50 = 25 μM, r12/15-LOX),27 thiourea-based (IC 50 = 1.8 μM, soybean 15-LOX)28 and thiadiazine (IC 50 = 9 μM, soybean 15-LOX)29 derivatives were developed as 15-LOX inhibitors, although they demonstrate a relatively low inhibitory potency. Recently, anacardic acid derived salicylates were described by our research group as LOX inhibitors 3032.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, five-membered heterocycles like pyrazole-based sulfonamide and sulfamides (IC 50 = 1.4 nM, r12/15-LOX),23 oxadiazole or oxazole derivatives as ML094 (IC 50 = 10 nM, h-15-LOX-1)24 and ML351 (IC 50 = 200 nM, h-15-LOX-1)25 but also imidazole-based compounds (IC 50 = 75 nM, r12/15-LOX)26 are reported as 15-LOX inhibitors. In addition, indolizine (IC 50 = 25 μM, r12/15-LOX),27 thiourea-based (IC 50 = 1.8 μM, soybean 15-LOX)28 and thiadiazine (IC 50 = 9 μM, soybean 15-LOX)29 derivatives were developed as 15-LOX inhibitors, although they demonstrate a relatively low inhibitory potency. Recently, anacardic acid derived salicylates were described by our research group as LOX inhibitors 3032.…”
Section: Introductionmentioning
confidence: 99%
“…Based on these findings and in continuation of our studies on the synthesis of potentially bioactive heterocyclic compounds , we wish to report on the synthesis and regiochemistry of new pyrimido[4,5‐ e ][1,2,4]triazolo[3,4‐ b ][1,3,4]thiadiazine derivatives.…”
Section: Introductionmentioning
confidence: 99%
“…In view of the aforementioned facts and also in continuation of our research program on the synthesis of new heterocyclic compounds [18,24,25], in this study, we wish to report on the synthesis of new derivatives of benzo [b]pyrimido [5,4-e] [1,4]thiazin-2-yl) morpholine.…”
Section: Introductionmentioning
confidence: 99%